From STAT: Despite accusing the pharmaceutical industry of “getting away with murder” by charging high drug prices, President Trump is now giving drug companies more power to charge higher prices overseas. Their price monopolies are likely to be extended under a draft executive order promising greater intellectual property protection in trade agreements.
